We are investigating whether acalabrutinib is safe and effective for adults with chronic lymphocytic leukemia and heart problems. This study compares it to other treatment options available for these patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Lymphocytic Leukaemia (CLL) is a type of cancer that affects the blood and bone marrow, characterized by the overproduction of lymphocytes. When combined with moderate to severe cardiac impairment, it can complicate treatment and management, leading to symptoms related to both the leukaemia and heart function.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
